ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,917Medicare Part D Prescriptions Filled, Including Refills

Rank: 416 out of 780

$279K Total Retail Price of All Prescriptions

Rank: 502 out of 780

358 Patients Receiving at Least One Drug in Part D
53%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 358 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 358 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

8% of this provider’s 3,653 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
CYCLOBENZAPRINE HCL 346 181 R 1 42
HYDROCODONE-ACETAMINOPHEN 302 129 S3 2 1
TRAMADOL HCL 298 130 3 15
LEVOTHYROXINE SODIUM 280 180 4 5
MELOXICAM 255 161 5 16
OMEPRAZOLE 252 148 6 3
LISINOPRIL 232 146 7 6
GABAPENTIN 209 90 8 13
METFORMIN HCL 158 79 9 8
CIPROFLOXACIN HCL 157 78 10 49
GEMFIBROZIL 135 65 11 104
SINGULAIR 123 50 12 73
CITALOPRAM HBR 118 52 13 23
ZOLPIDEM TARTRATE 106 36 14 17
SULFAMETHOXAZOLE-TRIMETHOPRIM 99 55 15 88
DICLOFENAC SODIUM 97 56 16 137
SIMVASTATIN 97 63 16 2
ATENOLOL 91 56 18 21
FUROSEMIDE 89 39 19 7
CRESTOR 80 36 20 32
HYDROCHLOROTHIAZIDE 79 56 21 10
METHYLDOPA 77 71 R 22 333
BUMETANIDE 73 59 23 96
METOPROLOL TARTRATE 69 45 24 19
AMITRIPTYLINE HCL 68 12 R 25 48
NEXIUM 65 22 26 22
AMLODIPINE BESYLATE 63 32 27 4
WARFARIN SODIUM 62 29 28 24
PAROXETINE HCL 53 20 29 69
MONTELUKAST SODIUM 52 22 30 120
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 28 31 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.